Bayer Aktiengesellschaft (ETR:BAYN)
22.07
-0.50 (-2.22%)
Mar 31, 2025, 2:45 PM CET
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 90,587 employees as of December 31, 2024. The number of employees decreased by 6,344 or -6.54% compared to the previous year.
Employees
90,587
Change (1Y)
-6,344
Growth (1Y)
-6.54%
Revenue / Employee
€514,489
Profits / Employee
€28,172
Market Cap
22.17B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 90,587 | -6,344 | -6.54% |
Dec 31, 2023 | 96,931 | -991 | -1.01% |
Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
Dec 31, 2021 | 95,950 | -5 | -0.01% |
Dec 31, 2020 | 95,955 | -2,782 | -2.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Merck KGaA | 59,020 |
Siemens Healthineers AG | 72,000 |
Fresenius SE & Co. KGaA | 176,486 |
Sartorius Aktiengesellschaft | 13,528 |
Fresenius Medical Care AG | 111,513 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 23,412 |
SCHOTT Pharma AG & Co. KGaA | 4,690 |
Bayer Aktiengesellschaft News
- 4 days ago - Elliott held talks with private equity as it considered new Bayer campaign - Financial Times
- 5 days ago - Bayer in licenses Puhe BioPharma’s cancer candidate - Seeking Alpha
- 5 days ago - Bayer acquires rights in Puhe BioPharma cancer drug candidate - Reuters
- 6 days ago - ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney Disease in Type 2 Diabetes - Business Wire
- 6 days ago - Bayer told to pay almost $2.1bn over Roundup cancer link claim - Independent Ireland
- 6 days ago - Monsanto parent ordered to pay $2B in Roundup lawsuit damages - The Hill
- 6 days ago - Bayer Stock Slumps After Firm Ordered To Pay More Than $2B in Latest Roundup Case - Investopedia
- 6 days ago - Push-pull over glyphosate in Germany - EURACTIV.com